The PATCH II trial even included patients after their first episode, but the observed reduction in recurrence did not reach statistical significance, leaving the evidence insufficient for definitive clinical recommendations [ 30 ].
← all excerpts
Recurrent Erysipelas: Clinical Challenges and Strategies for Prevention-A Narrative Literature Review.
1
—
—